This afternoon, Constellation Alpha Capital Corp. (CNAC), released the details of their shareholder vote to approve their merger with Dermtech, Inc., and there weren’t any surprises. The combination was approved with 4,218,390 “yes” votes and only 450,000 votes in the “no” column, however, 714,075 shares opted to redeem. That left approximately 473,457 shares as the public float.
However, there are 1,437,500 rights shares that will be delivered at closing, which means the total number of shares outstanding for DermTech (post that rights shares delivery) will be 1,910,957 before the reverse two-for-one stock split. If we factor in the reverse split, the public float will actually be 955,478, which is just shy of the 1 million needed to comply with Nasdaq’s listing standards.
However, Nasdaq had already issued a delisting notice AHEAD of the vote since CNAC did not comply with the minimum 300 public holders. It’s a little unclear if a delisting will happen immediately or if CNAC will get to go through the appeal process since the new Nasdaq rules have only been around since August 5th. Perhaps the Nasdaq will give CNAC some wiggle room via the appeal process to comply. However, the fact that CNAC did not provide new symbols in the 8-K for DermTech might mean that its a little unclear to CNAC as well. In the meantime, the new symbols that were listed in the final proxy are DMTK and DMTKW for the shares and warrants, respectively.
Finally, CNAC said that they “expect to consummate the Transaction in the near term,” but an expected date was not provided. Lots of question marks still out there on this de-SPACing. Hopefully we get some clarity soon.
| FOR | AGAINST | ABSTAIN |
| 4,218,390 | 450,000 | 0 |
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: NYSE president says IPO proceeds fall more than 90% while Nasdaq president remains hopeful for 2023, and Giuliani brothers sell pharma stocks as they invest in biotech SPACs NYSE president says IPO proceeds fall...
InterPrivate II Acquisition Corp. (NYSE:IPVA) disclosed this morning that it has restructured its bonus share agreement in connection to its proposed merger with carsharing marketplace Getaround. The parties previously agreed to reserve and set aside the bonus shares, consisting of 9,333,333 shares, to be allocated to the non-redeeming public stockholders, the designees of EarlyBirdCapital and the...
Iris Acquisition Corp. (NASDAQ:IRAA) has entered into a definitive agreement to combine with biotech firm Liminatus at an enterprise value of $334 million. La Palma, California-based Liminatus is a clinical-stage drug developer working on a range of cancer treatments utilizing both preventative vaccines and CAR-T therapies. The combined company is expected to trade on the...
Lakeshore Acquisition Corp. I (NASDAQ:LAAA) announced this morning that it has entered into a non-redemption agreement and amended its purchaser support agreement with initial shareholders in connection to its proposed merger with medical device company ProSomnus. The SPAC entered into non-redemption agreements with certain institutional investors for an aggregate of 200,339 shares of the purchaser. These investors...
The companies and sponsors of six SPAC deals are set to see their lock-ups expire before the end of the year. This is a relatively small monthly total as the wave of deals from 2020 and 2021 are still hitting this milestone. The list nonetheless includes some major names starting with Forafric (NASDAQ:AFRI), which is...